Compare Alibaba Group (BABA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alibaba Group vs Zimmer Biomet Holdings Inc — how do they compare? Alibaba Group trades at $125.1 (market cap $308.93B), while Zimmer Biomet Holdings Inc trades at $97.03 (market cap $18.55B). The key difference: Alibaba Group is far larger — about 16.7× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (0.99%). Which is the better fit depends on your goals.
| BABA | ZBH | |
|---|---|---|
Market Cap | $308.93B | $18.55B |
Volume | 18,069,938 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $189.34 | $107.71 |
52-Week Low | $94.83 | $79.58 |
Enterprise Value | $303.72B | $25.61B |
Dividend Yield | 0.82% | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alibaba (BABA) trades at $124.80, down 5.69% on the day amid ongoing legal pressures and earnings misses. The stock shows bullish technical signals with strong moving average support but faces fundamental headwinds from three consecutive quarterly EPS misses. Revenue growth remains positive at $996.35 billion for 2025, with improved net income margin of 13.05%, though cash flow turned negative at -$97.16 billion due to heavy investing activity.
Despite analyst optimism with 86% buy ratings and $195 consensus target, significant legal risks from multiple class action lawsuits and recent earnings underperformance create near-term uncertainty. The 56% upside to target suggests potential value if legal and operational challenges resolve, but investors face elevated regulatory and execution risks in the Chinese market environment.
Zimmer Biomet (ZBH) trades at $97.9, up 0.12% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology. Key financials show a P/E of 23.6 and net income margin of 9.48%, while cash flow from operations improved to $1.70B in 2025.
The outlook is positive, with a consensus price target of $103.56 offering ~6% upside. Risks include competitive pressures and margin volatility, but consistent earnings beats and institutional accumulation support a constructive view for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alibaba Group
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
